Cytokeratin 17 (KRT17) (Basal Epithelial Marker) Antibody, IgG2b, Clone: [SPM560], Mouse, Monoclonal

Catalog Number: NBT-3872-MSM1X-P1ABX
Article Name: Cytokeratin 17 (KRT17) (Basal Epithelial Marker) Antibody, IgG2b, Clone: [SPM560], Mouse, Monoclonal
Biozol Catalog Number: NBT-3872-MSM1X-P1ABX
Supplier Catalog Number: 3872-MSM1X-P1ABX
Alternative Catalog Number: NBT-3872-MSM1X-P1ABX-100
Manufacturer: NeoBiotechnologies
Host: Mouse
Category: Antikörper
Application: FC, IF, IHC, WB
Species Reactivity: Bovine, Goat, Human, Porcine, Rat
Immunogen: The cytoskeletal fraction of rat colon epithelium
Alternative Names: K17, Keratin Type I Cytoskeletal 17, Keratin-17, KRT17, PCHC1
Cytokeratin 17 (CK17) is a member of the Cytokeratin subfamily of intermediate filament proteins (IFPs). It is unique in that it is normally expressed in the basal cells of complex epithelia but not in stratified or simple epithelia. CK17 is expressed in the nail bed, hair follicle, sebaceous glands and other epidermal appendages. Antibody to CK17 is an excellent tool to distinguish myoepithelial cells from luminal epithelium of various glandssuch as mammary, sweat and salivary. CK17 is expressed in epithelial cells of various origins, such as bronchial epithelial cells and skin appendages. It may be considered as epithelial stem cell marker because CK17 Ab marks basal cell differentiation. CK17 can be useful when included in a panel of antibodies against TTF-1, napsin A, CK56, p63, and SOX-2 for diagnostic differentiation between lung adenocarcinoma (LADC) and lung squamous cell carcinoma (SCLC), especially for poorly-differentiated lung carcinoma. CK17 is expressed in SCLC much higher than in LADC. In breast carcinomas, approximately 20% of patients show no expression of ER, PR and Her2, which are defined as triple negative tumor. Eighty-five percent of the triple negative breast carcinomas immunoreact with basal cytokeratins including anti-CK17. Also important is that cases of triple negative breast carcinoma with expression of CK17 show an aggressive clinical course. The histologic differentiation of ampullary cancer, intestinal vs. pancreatobiliary, is very important for treatment. Usually anti-CK17 and anti-MUC1 immunoreactivity represents pancreatobiliary subtype whereas anti-MUC2 and anti-CDX-2 positivity defines intestinal subtype.
Clonality: Monoclonal
Clone Designation: [SPM560]
Molecular Weight: 46kDa
Isotype: IgG2b
NCBI: 3872
UniProt: Q04695
Form: 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Antibody Type: Monoclonal Antibody
Application Notes: Flow Cytometry (1-2ug/million cells), Immunofluorescence (1-2ug/ml), Western Blot (1-2ug/ml), Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA
Formalin-fixed, paraffin-embedded human skin stained with CK17 Monoclonal Antibody (SPM560).
Formalin-fixed, paraffin-embedded human skin stained with CK17 Monoclonal Antibody (SPM560).